PAtients With Symptomatic Peripheral Artery Disease on Rivaroxaban-acetylsalicylic Acid Combination Therapy (PRO-PAS)

NCT06239415 · clinicaltrials.gov ↗

UNKNOWN

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Atherosclerotic Disease

Interventions

OTHER: observation

Sponsor

Istituti Clinici Scientifici Maugeri SpA

Collaborators

[object Object]